The generated ROS can further activate the NF-κB pathway [89], which in turn enhances ROS production [90], forming a positive feedback loop that further promotes osteoblast dedifferentiation, creating a favorable growth environment for prostate cancer bone metastasis. Here, NFKB1 is linked to prostate cancer.